Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Many people in the United States take medications called proton pump inhibitors, or PPIs, to help with heartburn, acid reflux ...

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

Currently, doctors sometimes use a drug called spironolactone to treat this condition. It’s a medication that’s been around ...

Discover how to live successfully with one kidney through tips on protection, nutrition, and exercise. Learn the four ways ...

The latest findings provide reassurance for nephrologists who may be hesitant to prescribe these types of medications.

There, he receives dialysis for the kidney failure he was diagnosed with nearly 15 years ago. But the treatment, limited by ...

We can take simple steps to radically increase the number of kidneys available for transplant, but political inertia has ...

Hardworking Tennesseans have tried changes to diets and exercise to lose weight and maintain healthy lifestyles, but ...

Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.